Source:http://linkedlifedata.com/resource/pubmed/id/20677010
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-8-25
|
pubmed:abstractText |
It is well accepted that cell scattering (dispersion of clustered cells into single cells) is the initial step of tumor metastasis, and the downregulation of E-cadherin is associated with metastatic potential of tumor cells; however, the molecular mechanisms underlying loss of E-cadherin during tumor development are still poorly understood. Here, we report that hepatocyte growth factor (HGF) induced E-cadherin downregulation and cell scattering are attributed to the activation of Wnt/beta-catenin signaling and transcriptional activation of matrix metalloproteinase MMP-7. Furthermore, the increased MMP-7 is secreted into the medium and cleaves the ectodomain of E-cadherin. Inhibition of HGF signal by siRNA of c-Met, blocking the beta-catenin transcriptional activity through a dominant negative form of TCF4, MMP-7 knockdown by siRNA or suppression of MMP-7 enzymatic activity with a neutralization antibody allowed inhibition of HGF-induced loss of E-cadherin and HepG2 scattering. Our data presented here revealed the intrinsic mechanism of HGF activated Wnt/beta-catenin signaling regulation of HepG2 cell scattering through MMP-7 transcription activation and E-cadherin degradation. The results suggest that the blocking of HGF/c-Met/beta-catenin/MMP-7/E-cadherin signaling pathway might present a practical therapeutic target for interference with hepatocellular carcinoma metastasis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 7,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-met,
http://linkedlifedata.com/resource/pubmed/chemical/Wnt Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1432-119X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
285-95
|
pubmed:meshHeading |
pubmed-meshheading:20677010-Cadherins,
pubmed-meshheading:20677010-Down-Regulation,
pubmed-meshheading:20677010-Enzyme Activation,
pubmed-meshheading:20677010-Hep G2 Cells,
pubmed-meshheading:20677010-Hepatocyte Growth Factor,
pubmed-meshheading:20677010-Humans,
pubmed-meshheading:20677010-Matrix Metalloproteinase 7,
pubmed-meshheading:20677010-Neoplasm Invasiveness,
pubmed-meshheading:20677010-Neoplasm Metastasis,
pubmed-meshheading:20677010-Proto-Oncogene Proteins c-met,
pubmed-meshheading:20677010-Signal Transduction,
pubmed-meshheading:20677010-Wnt Proteins,
pubmed-meshheading:20677010-beta Catenin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription.
|
pubmed:affiliation |
Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|